Eligibility:
- The article must be a peer-reviewed, original research article published during the period from 2025 to 2026 (i.e., articles in volumes published in 2025-2026).
- The corresponding author must be affiliated with a Finnish university.
- Any author may submit the nomination on behalf of all co-authors.
Please include the following information in your nomination:
- Full names and contact information of all authors.
- Title of the article and a link to its electronic version.
- Full bibliographic citation of the article (including title, authors, journal name, year, volume, issue, pages, and DOI).
- Description of the important aspects and outstanding merits of the article, especially from the pharmaceutical point of view (maximum length 150 words). The aim is to provide the evaluation committee with information on the article’s contribution to the represented research area, and the novelty, importance, and originality of the research.